Home Research Locations About us Organization Staff Contacts Education Login Documents IT
Projects highlights

INCIPIT
(External link)

ISTAPCA
(964 views)

 INMiND
(980 views)

Fondo Europeo Pesca
(343 views)

Fondazione Veronesi
(External link)

Instruct-IT
(External link)

Euro-BioImaging
(External link)

 PRIN
(1107 views)

 eHealthNet
(909 views)

  Ponrec
(858 views)

MFAG Grant
(939 views)

(110 views)

MERIT
(External link)


Links

 |<  < >  >| 

    Export to BibTeX    Export to EndNote

Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer (64 views) (PDF public 13 views)

Greco A, Auletta L, Orlandella FM, Iervolino PLC, Klain M, Salvatore G, Mancini M

Int J Mol Sc, 2017 Dec; 18: 1-18.

Abstract
Abstract: Thyroid cancer, which represents the most common tumors among endocrine malignancies,
comprises a wide range of neoplasms with different clinical aggressiveness. One of the most important
challenges in research is to identify mouse models that most closely resemble human pathology;
other goals include finding a way to detect markers of disease that common to humans and mice and
to identify the most appropriate and least invasive therapeutic strategies for specific tumor types.
Preclinical thyroid imaging includes a wide range of techniques that allow for morphological and
functional characterization of thyroid disease as well as targeting and in most cases, this imaging
allows quantitative analysis of the molecular pattern of the thyroid cancer. The aim of this review
paper is to provide an overview of all of the imaging techniques used to date both for diagnosis and
theranostic purposes in mouse models of thyroid cancer.

Affiliations ▼
*** IBB - CNR Affiliation

Details ▼
Impact factor: 3.226, 5-year impact factor: 0

Paper type: Journal Article

Keywords: Thyroid Cancer, Preclinical Imaging, Ultrasound, Nuclear Medicine, Theranostic, Mouse Models

Url: Not available.

References ▼
1. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 2017, 67, 7–30. [CrossRef]

2. Kitahara, C.M.; Sosa, J.A. The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 2016, 12, 646–653.

3. Fagin, J.A.; Wells, S.A., Jr. Biologic and Clinical Perspectives on Thyroid Cancer. N. Engl. J. Med. 2016, 375,1054–1067. [CrossRef] [PubMed]

4. Dralle, H.; Machens, A.; Basa, J.; Fatourechi, V.; Franceschi, S.; Hay, I.D.; Nikiforov, Y.E.; Pacini, F.; Pasieka, J.L.; Sherman, S.I. Follicular cell-derived thyroid cancer. Nat. Rev. Dis. Primers 2015, 1. [CrossRef] [PubMed]

5. Nikiforov, Y.E.; Nikiforova, M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011, 7, 569–580. [CrossRef] [PubMed]

6. Molinaro, E.; Romei, C.; Biagini, A.; Sabini, E.; Agate, L.; Mazzeo, S.; Materazzi, G.; Sellari-Franceschini, S.; Ribechini, A.; Torregrossa, L.; et al. Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 2017, 13, 644–660. [CrossRef] [PubMed]

7. Xu, B.; Ghossein, R. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma. Endocr. Pathol. 2016, 27, 205–212. [CrossRef] [PubMed]

8. Maia, A.L.; Wajner, S.M.; Vargas, C.V. Advances and controversies in the management of medullary thyroid carcinoma. Curr. Opin. Oncol. 2017, 29, 25–32. [CrossRef] [PubMed]

9. Agrawal, N.; Akbani, R.; Aksoy, B.A.; Ally, A.; Arachchi, H.; Asa, S.L.; Auman, J.T.; Balasundaram, M.; Balu, S.; Baylin, S.B.; et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014, 159, 676–690. [CrossRef] [PubMed]

10. Howell, G.M.; Hodak, S.P.; Yip, L. RAS mutations in thyroid cancer. Oncologist 2013, 18, 926–932. [CrossRef]

11. Raman, P.; Koenig, R.J. Pax-8-PPAR-gamma fusion protein in thyroid carcinoma. Nat. Rev. Endocrinol. 2014, 10, 616–623. [CrossRef] [PubMed]

12. Asa, S.L.; Ezzat, S. The epigenetic landscape of differentiated thyroid cancer. Mol. Cell. Endocrinol. 2017.

13. Accardo, G.; Conzo, G.; Esposito, D.; Gambardella, C.; Mazzella, M.; Castaldo, F.; Di Donna, C.; Polistena, A.; Avenia, N.; Colantuoni, V.; et al. Genetics of medullary thyroid cancer: An overview. Int. J. Surg. 2017, 41, S2–S6. [CrossRef] [PubMed]

14. Walrath, J.C.; Hawes, J.J.; Van Dyke, T.; Reilly, K.M. Genetically engineered mouse models in cancer research. Adv. Cancer Res. 2010, 106, 113–164. [PubMed]

15. Doyle, A.; McGarry, M.P.; Lee, N.A.; Lee, J.J. The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res. 2012, 21, 327–349. [CrossRef] [PubMed]

16. Rusinek, D.; Krajewska, J.; Jarzab, M. Mouse models of papillary thyroid carcinoma—Short review. Endokrynol. Pol. 2016, 67, 212–223. [CrossRef] [PubMed]

17. Kirschner, L.S.; Qamri, Z.; Kari, S.; Ashtekar, A. Mouse models of thyroid cancer: A 2015 update. Mol. Cell. Endocrinol. 2016, 421, 18–27. [CrossRef] [PubMed]

18. Vitale, G.; Gaudenzi, G.; Circelli, L.; Manzoni, M.F.; Bassi, A.; Fioritti, N.; Faggiano, A.; Colao, A. Animal models of medullary thyroid cancer: State of the art and view to the future. Endocr. Relat. Cancer 2017, 24, R1–R12. [CrossRef] [PubMed]

19. Li, D.D.; Zhang, Y.F.; Xu, H.X.; Zhang, X.P. The role of BRAF in the pathogenesis of thyroid carcinoma. Front. Biosci. 2015, 20, 1068–1078.

20. Knauf, J.A.; Ma, X.; Smith, E.P.; Zhang, L.; Mitsutake, N.; Liao, X.H.; Refetoff, S.; Nikiforov, Y.E.; Fagin, J.A. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res. 2005, 65, 4238–4245. [CrossRef] [PubMed] Int. J. Mol. Sci. 2017, 18, 2731 15 of 18

21. Chakravarty, D.; Santos, E.; Ryder, M.; Knauf, J.A.; Liao, X.H.; West, B.L.; Bollag, G.; Kolesnick, R.; Thin, T.H.; Rosen, N.; et al. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J. Clin. Investig. 2011, 121, 4700–4711. [CrossRef [PubMed]

22. Russell, J.P.; Powell, D.J.; Cunnane, M.; Greco, A.; Portella, G.; Santoro, M.; Fusco, A.; Rothstein, J.L. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene 2000, 19, 5729–5735. [CrossRef] [PubMed]

23. Cunha, L.L.; Marcello, M.A.; Ward, L.S. The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr. Relat. Cancer 2014, 21, R85–R103. [CrossRef] [PubMed]

24. Taylor, E.; Heyland, A. Evolution of thyroid hormone signaling in animals: Non-genomic and genomic modes of action. Mol. Cell. Endocrinol. 2017. [CrossRef] [PubMed]

25. Suzuki, H.; Willingham, M.C.; Cheng, S.Y. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: A mouse model of thyroid carcinogenesis. Thyroid 2002, 12, 963–969. [CrossRef] [PubMed]

26. Kato, Y.; Ying, H.; Willingham, M.C.; Cheng, S.Y. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Endocrinology 2004, 145, 4430–4438. [CrossRef] [PubMed]

27. Kaneshige, M.; Kaneshige, K.; Zhu, X.; Dace, A.; Garrett, L.; Carter, T.A.; Kazlauskaite, R.; Pankratz, D.G.; Wynshaw-Boris, A.; Refetoff, S.; et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc. Natl. Acad. Sci. USA 2000, 97, 13209–13214. [CrossRef] [PubMed]

28. Velez-Cruz, R.; Johnson, D.G. The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts. Int. J. Mol. Sci. 2017, 18. [CrossRef] [PubMed]

29. Williams, B.O.; Remington, L.; Albert, D.M.; Mukai, S.; Bronson, R.T.; Jacks, T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat. Genet. 1994, 7, 480–484. [CrossRef] [PubMed]

30. Akeno, N.; Miller, A.L.; Ma, X.; Wikenheiser-Brokamp, K.A. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene 2015, 34, 589–599. [CrossRef] [PubMed]

31. Harvey, M.; Vogel, H.; Lee, E.Y.; Bradley, A.; Donehower, L.A. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 1995, 55, 1146–1151. [PubMed]

32. Kim, C.S.; Zhu, X. Lessons from mouse models of thyroid cancer. Thyroid 2009, 19, 1317–1331. [CrossRef]

33. Antonello, Z.A.; Nucera, C. Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF. Oncogene 2014, 33, 5397–5404. [CrossRef] [PubMed]

34. Greco, A.; Albanese, S.; Auletta, L.; Mirabelli, P.; Zannetti, A.; D’Alterio, C.; Di Maro, G.; Orlandella, F.M.; Salvatore, G.; Soricelli, A.; et al. High-Frequency Ultrasound-Guided Injection for the Generation of a Novel

35. Kim, S.; Park, Y.W.; Schiff, B.A.; Doan, D.D.; Yazici, Y.; Jasser, S.A.; Younes, M.; Mandal, M.; Bekele, B.N.; Myers, J.N. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Clin. Cancer Res. 2005, 11, 1713–1721. [CrossRef] [PubMed]

36. Ahn, S.H.; Henderson, Y.; Kang, Y.; Chattopadhyay, C.; Holton, P.; Wang, M.; Briggs, K.; Clayman, G.L. 2008, 134, 190–197. [CrossRef] [PubMed]

37. Nucera, C.; Nehs, M.A.; Mekel, M.; Zhang, X.; Hodin, R.; Lawler, J.; Nose, V.; Parangi, S. A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid 2009, 19, 1077–1084. [CrossRef] [PubMed]

38. Todaro, M.; Iovino, F.; Eterno, V.; Cammareri, P.; Gambara, G.; Espina, V.; Gulotta, G.; Dieli, F.; Giordano, S.; De Maria, R.; et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 2010, 70, 8874–8885. [CrossRef] [PubMed]

39. Tran Cao, H.S.; Kaushal, S.; Snyder, C.S.; Ongkeko, W.M.; Hoffman, R.M.; Bouvet, M. Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer. Anticancer Res. 2010, 30, 4415–4422. [PubMed]

40. Gule, M.K.; Chen, Y.; Sano, D.; Frederick, M.J.; Zhou, G.; Zhao, M.; Milas, Z.L.; Galer, C.E.; Henderson, Y.C.; Jasser, S.A.; et al. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin. Cancer Res. 2011, 17, 2281–2291. [CrossRef] [PubMed]

41. Buther, K.; Compeer, M.G.; De Mey, J.G.; Schober, O.; Schafers, M.; Bremer, C.; Riemann, B.; Holtke, C. Assessment of endothelin-A receptor expression in subcutaneous and orthotopic thyroid carcinoma xenografts in vivo employing optical imaging methods. Endocrinology 2012, 153, 2907–2918. [CrossRef]

42. Morrison, J.A.; Pike, L.A.; Lund, G.; Zhou, Q.; Kessler, B.E.; Bauerle, K.T.; Sams, S.B.; Haugen, B.R.; Schweppe, R.E. Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models. Horm. Cancer 2015, 6, 87–99. [CrossRef] [PubMed]

43. Zhou, M.; Chen, Y.; Adachi, M.; Wen, X.; Erwin, B.; Mawlawi, O.; Lai, S.Y.; Li, C. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials 2015, 57, 41–49.

44. Liu, Y.; Gunda, V.; Zhu, X.; Xu, X.; Wu, J.; Askhatova, D.; Farokhzad, O.C.; Parangi, S.; Shi, J. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proc. Natl. Acad. Sci. USA 2016, 113, 7750–7755. [CrossRef] [PubMed]

45. Reeb, A.N.; Ziegler, A.; Lin, R.Y. Characterization of human follicular thyroid cancer cell lines in preclinical mouse models. Endocr. Connect. 2016, 5, 47–54. [CrossRef] [PubMed]

46. Mo, J.H.; Choi, I.J.; Jeong, W.J.; Jeon, E.H.; Ahn, S.H. HIF-1alpha and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line. Cancer Sci. 2012, 103, 464–471. [CrossRef] [PubMed]

47. Nehs, M.A.; Nucera, C.; Nagarkatti, S.S.; Sadow, P.M.; Morales-Garcia, D.; Hodin, R.A.; Parangi, S. Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of

48. Yang, Y.J.; Na, H.J.; Suh, M.J.; Ban, M.J.; Byeon, H.K.; Kim, W.S.; Kim, J.W.; Choi, E.C.; Kwon, H.J.; Chang, J.W.; et al. Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1alpha. Yonsei Med. J. 2015, 56, 1503–1514.

49. Tentler, J.J.; Tan, A.C.; Weekes, C.D.; Jimeno, A.; Leong, S.; Pitts, T.M.; Arcaroli, J.J.; Messersmith, W.A.; Eckhardt, S.G. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 2012, 9, 338–350. [CrossRef] [PubMed]

50. Jauregui-Osoro, M.; Sunassee, K.; Weeks, A.J.; Berry, D.J.; Paul, R.L.; Cleij, M.; Banga, J.P.; O’Doherty, M.J.; Marsden, P.K.; Clarke, S.E.; et al. Synthesis and biological evaluation of [18F]tetrafluoroborate: A PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter. Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 2108–2116. [CrossRef] [PubMed]

51. Maschauer, S.; Michel, K.; Tripal, P.; Buther, K.; Kuwert, T.; Schober, O.; Kopka, K.; Riemann, B.; Prante, O. Synthesis and in vivo evaluation of an 18F-labeled glycoconjugate of PD156707 for imaging ETA receptor expression in thyroid carcinoma by positron emission tomography. Am. J. Nucl. Med. Mol. Imaging 2013, 3,

52. D’Alessandria, C.; Braesch-Andersen, S.; Bejo, K.; Reder, S.; Blechert, B.; Schwaiger, M.; Bartolazzi, A. Noninvasive In Vivo Imaging and Biologic Characterization of Thyroid Tumors by ImmunoPET Targeting of Galectin-3. Cancer Res. 2016, 76, 3583–3592. [CrossRef] [PubMed]

53. Liu, Q.; Pang, H.; Hu, X.; Li, W.; Xi, J.; Xu, L.; Zhou, J. Construction of human single-chain variable fragment antibodies of medullary thyroid carcinoma and single photon emission computed tomography/computed tomography imaging in tumor-bearing nude mice. Oncol. Rep. 2016, 35, 171–178. [CrossRef] [PubMed]

54. Yin, A.; Wang, C.; Sun, J.; Gao, J.; Tao, L.; Du, X.; Zhao, H.; Yang, J.; Li, Y. Overexpression of NDRG2 Increases Iodine Uptake and Inhibits Thyroid Carcinoma Cell Growth In Situ and In Vivo. Oncol. Res. 2016, 23, 43–51.

55. Ke, C.-C.; He, Z.-M.; Hsieh, Y.-J.; Huang, C.-W.; Li, J.-J.; Hwu, L.; Chen, Y.-A.; Yang, B.-H.; Chang, C.-W.; Huang, W.-S.; et al. Quantitative Measurement of the Thyroid Uptake Function of Mouse by Cerenkov Luminescence Imaging. Sci. Rep. 2017, 7. [CrossRef] [PubMed]

56. Jeong, S.Y.; Hwang, M.H.; Kim, J.E.; Kang, S.; Park, J.C.; Yoo, J.; Ha, J.H.; Lee, S.W.; Ahn, B.C.; Lee, J. Combined Cerenkov luminescence and nuclear imaging of radioiodine in the thyroid gland and thyroid cancer cells expressing sodium iodide symporter: Initial feasibility study. Endocr. J. 2011, 58, 575–583.

57. Levi, J.; Kothapalli, S.R.; Bohndiek, S.; Yoon, J.K.; Dragulescu-Andrasi, A.; Nielsen, C.; Tisma, A.; Bodapati, S.; Gowrishankar, G.; Yan, X.; et al. Molecular photoacoustic imaging of follicular thyroid carcinoma.

58. Orosco, R.K.; Savariar, E.N.; Weissbrod, P.A.; Diaz-Perez, J.A.; Bouvet, M.; Tsien, R.Y.; Nguyen, Q.T. Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model. J. Surg. Oncol. 2016, 113, 138–143. [CrossRef] [PubMed]

59. Mancini, M.; Vergara, E.; Salvatore, G.; Greco, A.; Troncone, G.; Affuso, A.; Liuzzi, R.; Salerno, P.; Scotto di Santolo, M.; Santoro, M.; et al. Morphological ultrasound microimaging of thyroid in living mice. Endocrinology 2009, 150, 4810–4815. [CrossRef] [PubMed]

60. Lavarello, R.J.; Ridgway, W.R.; Sarwate, S.S.; Oelze, M.L. Characterization of thyroid cancer in mouse models using high-frequency quantitative ultrasound techniques. Ultrasound Med. Biol. 2013, 39, 2333–2341.

61. Mancini, M.; Greco, A.; Salvatore, G.; Liuzzi, R.; Di Maro, G.; Vergara, E.; Chiappetta, G.; Pasquinelli, R.; Brunetti, A.; Salvatore, M. Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. BMC Med. Imaging 2013, 13. [CrossRef] [PubMed]

62. Zhou, L.; Zhang, M.; Fu, Q.; Li, J.; Sun, H. Targeted near infrared hyperthermia combined with immune stimulation for optimized therapeutic efficacy in thyroid cancer treatment. Oncotarget 2016, 7, 6878–6890.

63. Chen, X.; Zhu, H.; Huang, X.; Wang, P.; Zhang, F.; Li, W.; Chen, G.; Chen, B. Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancer. Nanoscale 2017, 9, 2219–2231. [CrossRef] [PubMed]

64. Buscombe, J.R. Radionuclides in the management of thyroid cancer. Cancer Imaging 2007, 7, 202–209.

65. Buscombe, J.; Hirji, H.; Witney-Smith, C. Nuclear medicine in the management of thyroid disease. Expert Rev. Anticancer Ther. 2008, 8, 1425–1431. [CrossRef] [PubMed]

66. Perron, B.; Rodriguez, A.M.; Leblanc, G.; Pourcher, T. Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J. Endocrinol. 2001, 170, 185–196. [CrossRef] [PubMed]

67. Ahn, B.C. Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated

68. Groot-Wassink, T.; Aboagye, E.O.; Glaser, M.; Lemoine, N.R.; Vassaux, G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human

69. Rao, B.; Zhang, R.; Li, L.; Shao, J.Y.; Wang, L.V. Photoacoustic imaging of voltage responses beyond the optical diffusion limit. Sci. Rep. 2017, 7. [CrossRef] [PubMed]

70. Greco, A.; Albanese, S.; Auletta, L.; De Carlo, F.; Salvatore, M.; Howard, C.M.; Claudio, P.P. Advances in molecular preclinical therapy mediated by imaging. Q. J. Nucl. Med. Mol. Imaging 2017, 61, 76–94. [PubMed]

71. Padhani, A.R.; Liu, G.; Mu-Koh, D.; Chenevert, T.L.; Thoeny, H.C.; Takahara, T.; Dzik-Jurasz, A.; Ross, B.D.; Van Cauteren, M.; Collins, D.; et al. Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations. Neoplasia 2009, 11, 102–125. [CrossRef] [PubMed]

72. Chen, Z.-Y.; Wang, Y.-X.; Lin, Y.; Zhang, J.-S.; Yang, F.; Zhou, Q.-L.; Liao, Y.-Y. Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy. BioMed Res. Int. 2014, 2014. [CrossRef]

73. Cui, Y.; Zhang, C.; Li, X.; Liu, H.; Yin, B.; Xu, T.; Zhang, Y.; Wang, D. Intravoxel Incoherent Motion Di usion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse. Sci. Rep. 2015, 5. [CrossRef] [PubMed]

74. Foroutan, P.; Kreahling, J.M.; Morse, D.L.; Grove, O.; Lloyd, M.C.; Reed, D.; Raghavan, M.; Altiok, S.; Martinez, G.V.; Gillies, R.J. Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy. PLoS ONE 2013, 8, e82875. [CrossRef] [PubMed]

75. Bozgeyik, Z.; Coskun, S.; Dagli, A.F.; Ozkan, Y.; Sahpaz, F.; Ogur, E. Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology 2009, 51, 193–198. [CrossRef] [PubMed]

76. Schob, S.; Voigt, P.; Bure, L.; Meyer, H.-J.; Wickenhauser, C.; Behrmann, C.; Höhn, A.; Kachel, P.; Dralle, H.; Hoffmann, K.-T.; et al. Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma—A Preliminary Study. Transl. Oncol. 2016, 9, 403–410. [CrossRef] [PubMed]

77. Shi, R.-Y.; Yao, Q.-Y.; Zhou, Q.-Y.; Lu, Q.; Suo, S.-T.; Chen, J.; Zheng, W.-J.; Dai, Y.-M.; Wu, L.-M.; Xu, J.-R. Preliminary study of diffusion kurtosis imaging in thyroid nodules and its histopathologic correlation. Eur. Radiol. 2017, 27, 4710–4720. [CrossRef] [PubMed]

78. Auletta, L.; Gramanzini, M.; Gargiulo, S.; Albanese, S.; Salvatore, M.; Greco, A. Advances in multimodal molecular imaging. Q. J. Nucl. Med. Mol. Imaging 2017, 61, 19–32. [PubMed]

79. Guernet, A.; Grumolato, L. CRISPR/Cas9 editing of the genome for cancer modeling. Methods 2017, 121–122, 130–137. [CrossRef] [PubMed]

80. Platt, R.J.; Chen, S.; Zhou, Y.; Yim, M.J.; Swiech, L.; Kempton, H.R.; Dahlman, J.E.; Parnas, O.; Eisenhaure, T.M.; Jovanovic, M.; et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 2014, 159, 440–455. [CrossRef] [PubMed] 


Related activities ▼
Clinical Oncology (255 views)

Related papers ▼
Advances in molecular preclinical therapy mediated by imaging (public domain) (42 views)
Preclinical imaging of thyroid (public domain) (13 views)

Related bibliography ▼

Content: [X]
Extended

Authors: [X]
AND Paper type: [X]

AND Start date: End date: [X]   AND Site:    AND  IBB affiliation

[Clear form]

<=2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018   ALL YEARS

Sort by: date    title    journal    authors      impact factor

* Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics (10 views)
Tavarelli M, Malandrino P, Vigneri P, Richiusa P, Maniglia A, Violi MA, Sapuppo G, Vella V, Dardanoni G, Vigneri R, Pellegriti G
Front Endocrinol (ISSN: 1664-2392print, 1664-2392linking), 2017 Oct 20; 8: 277-277.
View    Export to BibTeX    Export to EndNote

* Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy (8 views) (PDF 8 views)
Salvatore B, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M, Fonti R, Pellegrino T, Storto G, Cuocolo A, Pace L
Medicine (ISSN: 1536-5964electronic, 0025-7974linking), 2017 Oct; 96(42): e8344-e8344.
View    Export to BibTeX    Export to EndNote

* Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome (21 views)
Sapuppo G, Palermo F, Russo M, Tavarelli M, Masucci R, Squatrito S, Vigneri R, Pellegriti G
J Endocrinol Invest (ISSN: 1720-8386electronic, 0391-4097linking), 2017 Jun 23; N/D: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* Intake of Boron, Cadmium, and Molybdenum enhances rat thyroid cell transformation (39 views)
Vigneri R
J Exp Clin Cancer Res (ISSN: 1756-9966electronic, 0392-9078linking), 2017 Jun 02; 36(1): 73-73.
View    Export to BibTeX    Export to EndNote

* Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods (21 views)
Russo M, Malandrino P, Moleti M, Vermiglio F, Violi MA, Marturano I, Minaldi E, Vigneri R, Pellegriti G, Regalbuto C
J Endocrinol Invest (ISSN: 1720-8386electronic, 0391-4097linking), 2017 May 20; N/D: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment (23 views)
Russo M, Malandrino P, Moleti M, D'Angelo A, Tavarelli M, Sapuppo G, Giani F, Richiusa P, Squatrito S, Vigneri R, Pellegriti G
Anticancer Res (ISSN: 1791-7530electronic, 0250-7005linking), 2017 Mar; 37(3): 1515-1522.
View    Export to BibTeX    Export to EndNote

* Heavy metals in the volcanic environment and thyroid cancer (29 views)
Vigneri R, Malandrino P, Giani F, Russo M, Vigneri P
Mol Cell Endocrinol (ISSN: 1872-8057electronic, 0303-7207linking), 2016 Oct 26; N/D: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis (20 views)
Malandrino P, Russo M, Regalbuto C, Pellegriti G, Moleti M, Caff A, Squatrito S, Vigneri R
Thyroid (ISSN: 1557-9077electronic, 1050-7256linking), 2016 Sep; 26(9): 1285-1292.
View    Export to BibTeX    Export to EndNote

* Increased thyroid cancer incidence in a basaltic volcanic area is associated with non-anthropogenic pollution and biocontamination (25 views)
Malandrino P, Russo M, Ronchi A, Minoia C, Cataldo D, Regalbuto C, Giordano C, Attard M, Squatrito S, Trimarchi F, Vigneri R
Endocrine (ISSN: 1559-0100electronic, 1355-008xlinking), 2016 Aug; 53(2): 471-479.
View    Export to BibTeX    Export to EndNote

* Long period fiber grating nano-optrode for cancer biomarker detection (68 views) (PDF 80 views)
Quero G, Consales M, Severino R, Vaiano P, Boniello A, Sandomenico A, Ruvo M, Borriello A, Diodato L, Zuppolini S, Giordano M, Nettore IC, Mazzarella C, Colao A, Macchia PE, Santorelli F, Cutolo A, Cusano A
Biosens Bioelectron (ISSN: 1873-4235electronic, 0956-5663linking), 2016 Feb 13; 80: 590-600.
View    Export to BibTeX    Export to EndNote

* Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib (52 views)
Marotta V, Di Somma C, Rubino M, Sciammarella C, Modica R, Camera L, Del Prete M, Marciello F, Ramundo V, Circelli L, Buonomano P, Colao A, Faggiano A
Endocrine (ISSN: 1355-008x, 1559-0100electronic), 2015 Aug; 49(3): 854-858.
View    Export to BibTeX    Export to EndNote

* Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients (76 views)
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
Clin Nucl Med (ISSN: 1536-0229, 0363-9762, 1536-0229electronic), 2015 Feb; 40(2): 111-115.
View    Export to BibTeX    Export to EndNote

* Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients? (55 views)
Salvatore B, Caprio MG, Fonti R, D'Amico D, Fraioli F, Salvatore M, Pace L
Transl Med Unisa (ISSN: 2239-9747, 2239-9747electronic, 2239-9747linking), 2015 Jan; 11(6): 34-38.
View    Export to BibTeX    Export to EndNote

* Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression (74 views)
Zatelli MC, Tagliati F, Di Ruvo M, Castermans E, Cavazzini L, Daly AF, Ambrosio MR, Beckers A, degli Uberti E
Fam Cancer Kluwer Academic Publishers (ISSN: 1389-9600), 2014 Jun; 13(2): 273-280.
View    Export to BibTeX    Export to EndNote

* Radioiodide induces apoptosis in human thyroid tissue in culture (96 views)
Russo E, Guerra A, Faggiano A, Colao A, Del Vecchio S, Tonacchera M, Vitale M
(ISSN: 1355-008x), 2013 Dec; 44(3): 729-734.
View    Export to BibTeX    Export to EndNote

* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (72 views)
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
View    Export to BibTeX    Export to EndNote

* Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells (83 views)
Passaro C, Abagnale A, Libertini S, Volpe M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D, Portella G
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2013 Sep 19; 20(5): 633-647.
View    Export to BibTeX    Export to EndNote

* Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice (178 views)
Mancini M, Greco A, Salvatore G, Liuzzi R, Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A, Salvatore M
Bmc Medical Imaging (ISSN: 1471-2342), 2013 Sep 12; 13: 31-31.
View    Export to BibTeX    Export to EndNote

* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (123 views)
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
View    Export to BibTeX    Export to EndNote

* The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin (77 views)
D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A
European Journal Of Cancer (ISSN: 0959-8049), 2013 Mar; 49(5): 1142-1151.
View    Export to BibTeX    Export to EndNote

* Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms (76 views)
Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2013 Jan 30; 8(1): 22-22.
View    Export to BibTeX    Export to EndNote

* In regard to boomsma et al (119 views)
 Cella L, Conson M, Liuzzi R, Pacelli R
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2013 Jan 1; 85(1): 11-11.
View    Export to BibTeX    Export to EndNote

* Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma (108 views) (PDF 84 views)
Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2012 Apr 1; 82(5): 1802-1808.
View    Export to BibTeX    Export to EndNote

* Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607 (85 views)
Ocak M, Helbok A, Rangger C, Peitl PK, Nock BA, Morelli G, Eek A, Sosabowskijk, Breeman WA, Reubi JC, Decristoforo C
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2011 Sep; 38(8): 1426-1435.
View    Export to BibTeX    Export to EndNote

* Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131? (44 views)
Barbato F, Capacchione D, Nappi A, Telesca D, Tempone A, Casolino E, Nardelli A, Castaldi E, Ortosecco G, Storto G
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (110 views)
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
View    Export to BibTeX    Export to EndNote

* Morphological ultrasound microimaging of thyroid in living mice (80 views)
Mancini M, Vergara E, Salvatore G, Greco A, Troncone G, Affuso A, Liuzzi R, Salerno P, Scotto di Santolo M, Santoro M, Brunetti A, Salvatore M
Endocrinology (ISSN: 1945-7170, 0013-7227), 2009 Oct; 150(10): 4810-4815.
View    Export to BibTeX    Export to EndNote

* Peptides for tumour therapy and diagnosis: current status and future directions (121 views)
Zaccaro L, Del Gatto A, Pedone C, Saviano M
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2009 Mar; 16(7): 780-795.
View    Export to BibTeX    Export to EndNote

* Diagnostic value of FDG PET/CT imaging (63 views)
Pace L, Nicolai E, Klain M, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009; 53(5): 503-512.
View    Export to BibTeX    Export to EndNote

* Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3 (90 views)
Bartolazzi A, D'Alessandria C, Parisella MG, Signore A, Del Prete F, Lavra L, Braesch-Andersen S, Massari R, Trotta C, Soluri A, Sciacchitano S, Scopinaro F
Plos One (ISSN: 1932-6203, 1932-6203electronic), 2008 Nov 20; 3(11): e3768-e3768.
View    Export to BibTeX    Export to EndNote

* Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation (59 views)
Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2008 Mar; 52(1): 2-8.
View    Export to BibTeX    Export to EndNote

* BRAF(V600E) mutation and the biology of papillary thyroid cancer (62 views)
Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzoni E, Belfiore A, Vigneri R
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2008; 15(1): 191-205.
View    Export to BibTeX    Export to EndNote

* TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation (67 views)
Malaguarnera R, Vella V, Pandini G, Sanfilippo M, Pezzino V, Vigneri R, Frasca F
Mol Cancer Res (ISSN: 1541-7786), 2008; 6(1): 64-77.
View    Export to BibTeX    Export to EndNote

* Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update (92 views)
Cuocolo A, Milcinski M, Bischof Delaloye A
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Mar; 34(3): 433-436.
View    Export to BibTeX    Export to EndNote

* Radioisotope guided surgery with imaging probe, a hand-held high-resolution gamma camera (51 views) (PDF 54 views)
Soluri A, Trotta C, Scopinaro F, Tofani A, D'Alessandria C, Pasta V, Stella S, Massari R
Nuclear Instruments And Methods In Physics Research Section A, 2007; 583(2-3): 366-371.
View    Export to BibTeX    Export to EndNote

* The EEE project (55 views)
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M
Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980.
View    Export to BibTeX    Export to EndNote

* Prognostic indicators in patients with differentiated thyroid cancer receiving repeated I-131 therapies (60 views)
Storto G, Liuzzi R, Klain M, Albanese C, Salvatore B, Pellegrino T, Cella L, Soricelli A, Pace L, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment (90 views)
Pace L, Klain M, Albanese C, Salvatore B, Storto G, Soricelli A, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Feb; 33(2): 179-183.
View    Export to BibTeX    Export to EndNote

* Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy (54 views)
Pace L, Klain M, Soricelli A, Albanese C, Salvatore B, Storto G, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: 179-183.
View    Export to BibTeX    Export to EndNote

* Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis (115 views)
Cozzolino R, Palladino P, Rossi F, Cali G, Benedetti E, Laccetti P
Carcinogenesis (ISSN: 0143-3334), 2005 Apr; 26(4): 733-739.
View    Export to BibTeX    Export to EndNote

* Recombinant thyrotropin-induced orbital uptake of [In-111-diethylenetriamine-pentacetic acid-D-phe(1)]octreotide in a patient with inactive Graves' ophthalmopathy (52 views)
Savastano S, Pivonello R, Acampa W, Salvatore M, Lombardi G, Colao A, Fenzi G
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2005 Apr; 90(4): 2440-2444.
View    Export to BibTeX    Export to EndNote

* Postsurgical follow up of differentiated thyroid cancer using rhTSH (53 views)
Klain M, Pellegrino T, Storto G, Biondi B, Sansone V, Pagano L, Nicolai E, Della Morte A, D'Amico D, Soricelli A, Lombardi G, Pace L, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
View    Export to BibTeX    Export to EndNote

* In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging (62 views)
Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004 Feb; 19(1): 93-98.
View    Export to BibTeX    Export to EndNote

* ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells (85 views)
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M, Fusco A
J Clin Endocrinol Metab Journal Of Clinical Endocrinology And Metabolism (ISSN: 0021-972x), 2003 Oct 1; 88(10): 5027-5032.
View    Export to BibTeX    Export to EndNote

* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (67 views)
Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
View    Export to BibTeX    Export to EndNote

* Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer (53 views)
Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S
J Clin Endocrinol Metab (ISSN: 0021-972x), 2003 Jan; 88(1): 211-214.
View    Export to BibTeX    Export to EndNote

* Radiolabeling approaches for cholecystokinin B receptor imaging (93 views)
Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.
View    Export to BibTeX    Export to EndNote

The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (69 views)
Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
View    Export to BibTeX    Export to EndNote

Diagnostic and prognostic role of 99mTc-Tetrofosmin in breast cancer (61 views)
Mansi L, Rambaldi PF, Cuccurullo V, Pecori B, Quarantelli M, Fallanca F, Del Vecchio E
Association Of Radiopharmacology (ISSN: 1124-3937, 1125-0135), 1997 Sep; 41(3): 239-250.
View    Export to BibTeX    Export to EndNote

Technetium-99m tetrofosmin imaging in thyroid diseases: Comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methioxyisobutylisonitrile scans (62 views)
Klain M, Maurea S, Cuocolo A, Colao A, Marzano L, Lombardi G, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 0340-6997, 1619-7070, 1619-7089), 1996; 23(12): 1568-1574.
View    Export to BibTeX    Export to EndNote

Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (67 views)
Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Association Of Radiopharmacology (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
View    Export to BibTeX    Export to EndNote

Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer (53 views)
Klain M, Maurea S, Lastoria S, Cuocolo A, Colao A, Salvatore M
Journal Of Nuclear Medicine (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1995 Dec; 36(12): 2248-2251.
View    Export to BibTeX    Export to EndNote

TC-99M MIBI SCAN IN THE INITIAL EVALUATION AND POSTSURGICAL FOLLOW-UP OF THYROID-CANCER (59 views)
MAUREA S, LASTORIA S, KLAIN M, MASTRO A, VARRELLA P, ACAMPA W, CONZO G, FOJAJA M, SALVATORE M
Journal Of Nuclear Medicine (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
View    Export to BibTeX    Export to EndNote

TC-99M MIBI IMAGING IN THE INITIAL DIAGNOSIS AND POST-SURGERY FOLLOW-UP OF PATIENTS WITH THYROID CANCER (42 views)
MAUREA S, LASTORIA S, KLAIN M, GRIVETFOJAJA M, VARRELLA P, ACAMPA W, VERGARA E, MASTRO A, CONZO G, SALVATORE M
Posters Tomes 1 4proceedings Of The Xvi International Cancer Congress Free Papers And, 1994; N/D: N/D-N/D.
View    Export to BibTeX    Export to EndNote

PELVIC RADIOIODINE UPTAKE IN A RECTAL WALL TERATOMA AFTER THYROIDECTOMY FOR PAPILLARY CARCINOMA (68 views)
Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J
Journal Of Nuclear Medicine (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1992 Oct; 33(10): 1848-1850.
View    Export to BibTeX    Export to EndNote

Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (63 views)
Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Eur J Nucl Med Mol Imaging (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
View    Export to BibTeX    Export to EndNote

Multimetastatic Medullary Thyroid Carcinoma To The Breast: Pet/Ct - Mammographic - Us And Mr Findings (38 views)
Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
Breast J (ISSN: 1075-122x), N/D; 20(6): 653-654.
View    Export to BibTeX    Export to EndNote

Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients (50 views)
Pace L, Klain M, Salvatore B, Nicolai E, Zampella E, Assante R, Pellegrino T, Storto G, Fonti R, Salvatore M
Clin Nucl Med (ISSN: 0363-9762, 1536-6022, 1536-0229), N/D; 40(2): 111-115.
View    Export to BibTeX    Export to EndNote



61 Records (55 excluding Abstracts and Conferences).
Total impact factor: 204.115 (184.078 excluding Abstracts and Conferences).
Total 5-year impact factor: 193.523 (170.056 excluding Abstracts and Conferences).



Your bibliography query: (([btitle, keywords, abstract] THYROID AND [btitle, keywords, abstract] CANCER)) AND NOT [id] = 53635



Last modified by Marco Comerci on Monday 18 December 2017, 13:46:08
64 views. Last viewed on Wednesday 21 February 2018, 16:56:31

Webmaster and developer: Marco Comerci
For problems and suggestions: adminibb.cnr.it
Last updated: Thursday 22 February 2018, 11:53:02